Investigational beta-emitting radionuclide therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational beta-emitting radionuclide therapy, covering 2025-12-17 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma [Phase 2]